RankingsPricing
  1. JP-listed companies
  2. NANO MRNA Co.,Ltd.
  3. Financials
  4. Operating income

NANO MRNA Co.,Ltd.【JP:4571】

Market cap
¥10.3B
P/E ratio
-9.9x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndOperating income (Million JPY)YoY (%)
Mar 31, 2025-755-12.62%
Mar 31, 2024-864-30.62%
Mar 31, 2023-1,246-39.55%
Mar 31, 2022-2,061+58.19%
Mar 31, 2021-1,303+17.82%
Mar 31, 2020-1,106-38.65%
Mar 31, 2019-1,802-66.32%
Mar 31, 2018-5,351+97.31%
Mar 31, 2017-2,712+30.23%
Mar 31, 2016-2,083+87.93%
Mar 31, 2015-1,108

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)